These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7363710)

  • 1. Clinical pharmacology of a new ureidopenicillin: Bay K 49999.
    Lode H; Tomas W; Koeppe P; Wagner J
    Chemotherapy; 1980; 26(2):81-90. PubMed ID: 7363710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.
    Verbist L
    Antimicrob Agents Chemother; 1979 Aug; 16(2):115-9. PubMed ID: 485123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.
    Wise R; Cadge B; Gillett AP; Bhamjee A; Livingston R; Welling PG; Thornhill DP
    Antimicrob Agents Chemother; 1979 May; 15(5):670-3. PubMed ID: 525984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].
    Lode H; Niestrath U; Koeppe P; Langmaack H
    Infection; 1977; 5(3):163-9. PubMed ID: 334673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial spectrum of mezlocillin and azlocillin, two new antibiotics of the ureidopenicillin group (author's transl)].
    Roy C; Segura C; Fuster C; Tirado M; Foz A
    Med Clin (Barc); 1982 May; 78(9):363-71. PubMed ID: 6212725
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro effect of acylureido penicillins and mezlocillin on anaerobic sporeless gram-negative rods of genus Bacteroides].
    Höhne C
    Infection; 1982; 10 Suppl 3():S238-43. PubMed ID: 6218120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
    Bergan T; Thorsteinsson SB; Steingrimsson O
    Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the antibacterial activity of two new acylureidopenicillins, mezlocillin and azlocillin.
    Soares LA; Trabulsi LR
    Arzneimittelforschung; 1979; 29(12a):1932-4. PubMed ID: 543893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of azlocillin to treat serious infections.
    Neu HC; Francke EL; Ortiz-Neu C; Prince AS
    J Antimicrob Chemother; 1983 May; 11 Suppl B():141-7. PubMed ID: 6619023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mezlocillin and azlocillin: an evaluation of two new beta-lactam antibiotics.
    Ellis CJ; Geddes AM; Davey PG; Wise R; Andrews JM; Grimley RP
    J Antimicrob Chemother; 1979 Sep; 5(5):517-25. PubMed ID: 387705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of furazlocillin in healthy humans.
    Hinderling PH; Gundert-Remy U; Förster D; Gau W
    J Pharmacokinet Biopharm; 1983 Feb; 11(1):5-30. PubMed ID: 6875810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of azlocillin in the burn patient].
    Drugeon HB; Pannier M; Courtieu AL
    Presse Med; 1984 Mar; 13(13):805-7. PubMed ID: 6231599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibiotics.
    Reeves DS; Bywater MJ; Holt HA; Broughall JM
    Arzneimittelforschung; 1979; 29(12a):1920-9. PubMed ID: 543891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.